RP-HPLC method development and validation for determination of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms

Authors

  • Abdul Majid Ayatollahi Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Department of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Hossein Vahidi Department of pharmaceutical biotechnology, Faculty of pharmacy, Shahid Beheshti University of medical sciences, Tehran, Iran
  • Maryam Bavand Savadkouhi Department of pharmaceutical biotechnology, Faculty of pharmacy, Shahid Beheshti University of medical sciences, Tehran, Iran Students research committee, Faculty of pharmacy, Shahid Beheshti University of medical sciences, Tehran, Iran
  • Shirin Hooshfar Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:

A new, rapid, economical and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of eptifibatide acetate, a small synthetic antiplatelet peptide, in bulk drug substance and pharmaceutical dosage forms. The developed method was validated as per of ICH guidelines. The chromatographic separation was achieved isocratically on C18 column (150 x 4.60 mm i.d., 5µm particle size) at ambient temperature using acetonitrile (ACN), water and trifluoroacetic acid (TFA) as mobile phase at flow rate of 1 ml/min and UV detection at 275 nm. Eptifibatide acetate exhibited linearity over the concentration range of 0.15-2 mg/ml (r2=0.997) with limit of detection of 0.15 mg/ml. The accuracy of the method was 96.4-103.8%. The intra-day and inter-day precision were between 0.052% and 0.598%, respectively. The present successfully validated method with excellent selectivity, linearity, sensitivity, precision and accuracy was applicable for the assay of eptifibatide acetate in bulk drug substance and pharmaceutical dosage forms.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms

A new, rapid, economical and isocratic reverse phase high performance liquid chromatography (RP-HPLC) method was developed for the determination of eptifibatide acetate, a small synthetic antiplatelet peptide, in bulk drug substance and pharmaceutical dosage forms. The developed method was validated as per of ICH guidelines. The chromatographic separation was achieved isocratically on C18 colum...

full text

Development and Validation of RP-HPLC Method for Determination of Glibenclamide in Pharmaceutical Dosage Forms

A rapid, linear, precise, selective and accurate reverse phase HPLC method was developed and validated for simultaneous estimation of glibenclamide in tablet dosage form. The method employed for analysis using methanol as a solvent. The wavelength UV 300 nm was selected for estimation and linearity was observed in the concentration range of 160 240 μg/ml for glibenclamide respectively. The reco...

full text

Development and Validation of New Rp-hplc Method for Determination of Acetyl Sulfisoxazole in Bulk and Pharmaceutical Dosage Forms

Received: April 12, 2011 / Revised: April 17, 2011 / Accepted: April 18, 2011 A simple and precise RP‐HPLC method was developed and validated for the determination of acetyl sulfisoxazole in blood samples. Chromatography was carried out using methanol:acetonitrile:0.01M potassium dihydrogen phosphate (25:50:25 v/v) as the mobile phase at a flow rate 1.2 ml/min. The analyte was monitored by usin...

full text

Development and Validation of a Reversed-phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms

A gradient reversed-phase high performance liquid chromatography (HPLC) method was developed for the assay of cetrorelix acetate, a synthetic decapeptide with gonadotropin-releasing hormone (GnRH) antagonistic activity used in infertility treatment. The HPLC method, which is used to determine cetrorelix in bulk and pharmaceutical dosage forms, was validated per ICH guidelines. The chromatograph...

full text

Development and Validation of a Reversed-phase HPLC Method for Assay of the Decapeptide Cetrorelix Acetate in Bulk and Pharmaceutical Dosage Forms

A gradient reversed-phase high performance liquid chromatography (HPLC) method was developed for the assay of cetrorelix acetate, a synthetic decapeptide with gonadotropin-releasing hormone (GnRH) antagonistic activity used in infertility treatment. The HPLC method, which is used to determine cetrorelix in bulk and pharmaceutical dosage forms, was validated per ICH guidelines. The chromatograph...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 16  issue 2

pages  490- 497

publication date 2017-06-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023